Literature DB >> 10076904

Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain.

D Levy1, A Höke, D W Zochodne.   

Abstract

Peripheral nerve injury is associated with local inflammation and neuropathic pain. In this study we investigated the local expression of the inducible isoform of nitric oxide synthase (iNOS) following a chronic constriction injury (CCI) to the sciatic nerve, a rat model of neuropathic pain. Western blot analysis and immunohistochemical co-localization methods were used to identify temporal and spatial expression of iNOS and its cells of origin. Changes in mRNA were analyzed by RT-PCR and iNOS specific primers. We report that CCI injury induced local iNOS expression in both macrophages and Schwann cells within and distal to the injury site. The local increase in iNOS mRNA expression paralleled both the temporal and spatial protein expression. This study supports the hypothesis that CCI is associated with a local inflammatory reaction mediated at least in part by iNOS. Local activation of the iNOS-NO system may play an important role in the pathogenesis of peripheral nerve injury and neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10076904     DOI: 10.1016/s0304-3940(98)00982-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  27 in total

Review 1.  The role of nitric oxide in nociception.

Authors:  Z D Luo; D Cizkova
Journal:  Curr Rev Pain       Date:  2000

2.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

Review 3.  Neural regeneration: lessons from regenerating and non-regenerating systems.

Authors:  Leonardo M R Ferreira; Elisa M Floriddia; Giorgia Quadrato; Simone Di Giovanni
Journal:  Mol Neurobiol       Date:  2012-06-21       Impact factor: 5.590

4.  Identification of critical amino acid residues for human iNOS functional activity.

Authors:  Saule Naureckiene; Sreekumar R Kodangattil; Edward J Kaftan; Philip G Jones; Jeffrey D Kennedy; Kathryn E Rogers; Pranab K Chanda
Journal:  Protein J       Date:  2008-08       Impact factor: 2.371

5.  Establishment of a rodent model of HIV-associated sensory neuropathy.

Authors:  Sanjay C Keswani; Christelene Jack; Chunhua Zhou; Ahmet Höke
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

6.  Clinical significance of cerebrospinal fluid nitric oxide concentrations in degenerative cervical and lumbar diseases.

Authors:  Hiroshi Denda; Shinji Kimura; Akiyoshi Yamazaki; Noboru Hosaka; Yuichi Takano; Kenji Imura; Yoichi Yajiri; Naoto Endo
Journal:  Eur Spine J       Date:  2010-12-29       Impact factor: 3.134

7.  Capnellene, a natural marine compound derived from soft coral, attenuates chronic constriction injury-induced neuropathic pain in rats.

Authors:  Yen-Hsuan Jean; Wu-Fu Chen; Chun-Sung Sung; Chang-Yih Duh; Shi-Ying Huang; Chan-Shing Lin; Ming-Hon Tai; Shun-Fen Tzeng; Zhi-Hong Wen
Journal:  Br J Pharmacol       Date:  2009-08-05       Impact factor: 8.739

8.  Wallerian degeneration in C57BL/6J and A/J mice: differences in time course of neurofilament and myelin breakdown, macrophage recruitment and iNOS expression.

Authors:  Cristiane L R de la Hoz; Alexandre L R Oliveira; Luciano de S Queiroz; Francesco Langone
Journal:  J Anat       Date:  2003-12       Impact factor: 2.610

9.  Role of mitogen-activated protein kinase cascades in inducible nitric oxide synthase expression by lipopolysaccharide in a rat Schwann cell line.

Authors:  Haibo Wang; Chun Cheng; Yongwei Qin; Shuqiong Niu; Shangfeng Gao; Xin Li; Tao Tao; Aiguo Shen
Journal:  Neurochem Res       Date:  2008-07-31       Impact factor: 3.996

10.  A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.

Authors:  Wei-Ping Wu; Jing-Xia Hao; Ennio Ongini; Francesco Impagnatiello; Cristina Presotto; Zsuzsanna Wiesenfeld-Hallin; Xiao-Jun Xu
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.